Australia, Sept. 9 -- Arovella Therapeutics Ltd., owns the trademark (2518060) for 'Arovella' till Jan. 30, 2035.
Status: registered:
Registered/protected
Classes: 5 [Therapeutic drugs (medical); therapeutic agents (medical); therapeutic creams (medical); therapeutic biological products (medical); chemical products for therapeutical use; nutraceutical preparations for therapeutic or medical purposes; pharmaceutical preparations; pharmaceutical preparations for veterinary use; veterinary preparations; pharmaceutical preparations for oral use; throat sprays (medicated); mouth sprays for medical use; sedatives; pharmaceutical and medicinal preparations and substances] and 42 [Scientific research for medical purposes; clinical trials; conducting clinical trials; medical research; scientific research; drug development; drug development services; pharmaceutical research and development; pharmaceutical research; research and development of pharmaceuticals and vaccines; laboratory services (scientific research or analysis); management of scientific research projects; preparation of reports relating to scientific and medical research; research in the field of cell and gene therapy; advisory, consultancy and information services related to the foregoing]
Type of Mark: Word
Date of Acceptance: March 21
Registration Advertised: Sept. 8
For further details contact Davies Collison Cave Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2518060.
Disclaimer: Curated by HT Syndication.
